CuraLife
Natural Supplements for Treatment of Chronic Conditions
Company Overview
Snapshot
Founded in November 2013 by Ron Elul, Ofer Yigdal, Alberto Iore, Tal Zimerman, and Haviv Almog, CuraLife operates with 11–50 employees. The company has secured funding across one round from one investor.
Business overview
CuraLife is a Health Tech & Life Sciences company focused on maximizing patient health outcomes through nutraceutical offerings and digital therapeutics. The company has developed a chronic disease management platform that provides therapeutic supplements, peer-to-peer support, behavior therapy, and virtual care. Its flagship product, CuraLin, is a 100% natural glucose support supplement designed to help individuals maintain healthy blood sugar levels, blending ancient Ayurveda practices with modern science. CuraLife serves patients globally, with solutions adopted in over 50 countries, operating within the Pharmaceuticals and Digital Healthcare sectors.
Strategic signal
This investment signals continued investor confidence in CuraLife's approach to chronic disease management through natural supplements and digital therapeutics, suggesting potential for further market expansion and product development in the Health Tech & Life Sciences sector.
Log in to access full profile ›Company Intelligence Q&A
- What is CuraLife's primary product?
- CuraLife's primary product is CuraLin, a 100% natural glucose support supplement designed to help people with type 2 diabetes maintain healthy blood sugar levels.
- When was CuraLife founded and by whom?
- CuraLife was founded in November 2013 by Ron Elul, Ofer Yigdal, Alberto Iore, Tal Zimerman, and Haviv Almog.
- What was a significant partnership for CuraLife in 2020?
- In May 2020, CuraLife partnered with AsSeenOnTV.pro for a DRTV campaign featuring Kevin Harrington to promote CuraLin, a natural supplement for type 2 diabetes.
- What strategic move did CuraLife make regarding its medical advisory board in January 2020?
- In January 2020, CuraLife announced that Professor Itamar Raz, head of the Israeli National Council of Diabetes, would chair its medical advisory board and conduct clinical trials for CuraLin.
- What was a key development for CuraLife's online community in October 2021?
- In October 2021, CuraLife's online community surpassed 60,000 users, providing peer-to-peer global support for individuals managing chronic conditions.